A Tribute to Paul Greengard (1925-2019)
- 1st Edition, Volume 90 - March 2, 2021
- Imprint: Academic Press
- Editor: Stevin H. Zorn
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 2 2 5 1 6 - 5
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 2 2 5 1 7 - 2
A Tribute to Paul Greengard, Volume 90, the latest release in the Advances in Pharmacology series presents a variety of chapters from the best authors in the field, with this rel… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteA Tribute to Paul Greengard, Volume 90, the latest release in the Advances in Pharmacology series presents a variety of chapters from the best authors in the field, with this release presenting a tribute to Paul Greengard.
- Includes the authority and expertise of leading contributors in pharmacology
- Presents the latest release in the Advances in Pharmacology series
Investigators in neuroscience, pharmacology, neurology, psychiatry, medicine
1. Paul Greengard: A persistent desire to comprehend the brain, and also to fix it
Marc Flajolet, Thu Lan N-Guyen, Vijay Kumar Siripuram and Yashoda Krishna Sunkari
2. Giving names to the actors of synaptic transmission: The long journey from synaptic vesicles to neural plasticity
Fabio Benfenati, Martin Bähler and Flavia Valtorta
3. cAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatases
Kyle R. Christensen and Angus C. Nairn
4. DARPP-32 40 years later
Jean-Antoine Girault and Angus C. Nairn
5. Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction
Angela M. Lee and Marina R. Picciotto
6. Modulation of dendritic spines by protein phosphatase-1
Jimcy Platholi and Hugh C. Hemmings Jr
7. Deciphering cell-type specific signal transduction in the brain: Challenges and promises
Jean-Pierre Roussarie and Patricia Rodriguez-Rodriguez
8. Drug-activated cells: From immediate early genes to neuronal ensembles in addiction
Marine Salery, Arthur Godino and Eric J. Nestler
9. NAPE-specific phospholipase D regulates LRRK2 association with neuronal membranes
Francesca Palese, Silvia Pontis, Natalia Realini and Daniele Piomelli
10. Amyloidogenic and anti-amyloidogenic properties of presenilin 1
Victor Bustos, Maria Pulina and Jose Ledo
11. A review of the pharmacology and clinical profile of lumateperone for the treatment of schizophrenia
Gretchen L Snyder, Kimberly E Vanover, Robert E Davis, Peng Li, Allen Fienberg and Sharon Mates
12. Uniting homeostatic plasticity and exosome biology: A revision of the conceptual framework for drug discovery in neurodegenerative diseases?
James K.T. Wang
- Edition: 1
- Volume: 90
- Published: March 2, 2021
- No. of pages (Hardback): 326
- Imprint: Academic Press
- Language: English
- Hardback ISBN: 9780128225165
- eBook ISBN: 9780128225172
SZ
Stevin H. Zorn
Stevin Zorn is President and CEO at MindImmune Therapeutics, Inc., Kingston, RI, USA
Affiliations and expertise
President and CEO, MindImmune Therapeutics, Inc., Kingston, RI, USARead A Tribute to Paul Greengard (1925-2019) on ScienceDirect